387 related articles for article (PubMed ID: 21705022)
1. Motor and non-motor correlates of olfactory dysfunction in Parkinson's disease.
Berendse HW; Roos DS; Raijmakers P; Doty RL
J Neurol Sci; 2011 Nov; 310(1-2):21-4. PubMed ID: 21705022
[TBL] [Abstract][Full Text] [Related]
2. Striatal dopamine transporter imaging correlates with depressive symptoms and tower of London task performance in Parkinson's disease.
Rektorova I; Srovnalova H; Kubikova R; Prasek J
Mov Disord; 2008 Aug; 23(11):1580-7. PubMed ID: 18618663
[TBL] [Abstract][Full Text] [Related]
3. Hyposmia as a marker of (non-)motor disease severity in Parkinson's disease.
Roos DS; Twisk JWR; Raijmakers PGHM; Doty RL; Berendse HW
J Neural Transm (Vienna); 2019 Nov; 126(11):1471-1478. PubMed ID: 31515655
[TBL] [Abstract][Full Text] [Related]
4. Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients.
Erro R; Pappatà S; Amboni M; Vicidomini C; Longo K; Santangelo G; Picillo M; Vitale C; Moccia M; Giordano F; Brunetti A; Pellecchia MT; Salvatore M; Barone P
Parkinsonism Relat Disord; 2012 Nov; 18(9):1034-8. PubMed ID: 22789824
[TBL] [Abstract][Full Text] [Related]
5. Selective hyposmia and nigrostriatal dopaminergic denervation in Parkinson's disease.
Bohnen NI; Gedela S; Kuwabara H; Constantine GM; Mathis CA; Studenski SA; Moore RY
J Neurol; 2007 Jan; 254(1):84-90. PubMed ID: 17508142
[TBL] [Abstract][Full Text] [Related]
6. Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT.
Stiasny-Kolster K; Doerr Y; Möller JC; Höffken H; Behr TM; Oertel WH; Mayer G
Brain; 2005 Jan; 128(Pt 1):126-37. PubMed ID: 15548552
[TBL] [Abstract][Full Text] [Related]
7. [99mTc]TRODAT-1 SPECT imaging correlates with odor identification in early Parkinson disease.
Siderowf A; Newberg A; Chou KL; Lloyd M; Colcher A; Hurtig HI; Stern MB; Doty RL; Mozley PD; Wintering N; Duda JE; Weintraub D; Moberg PJ
Neurology; 2005 May; 64(10):1716-20. PubMed ID: 15911797
[TBL] [Abstract][Full Text] [Related]
8. Conversion to Parkinson Disease in the PARS Hyposmic and Dopamine Transporter-Deficit Prodromal Cohort.
Jennings D; Siderowf A; Stern M; Seibyl J; Eberly S; Oakes D; Marek K;
JAMA Neurol; 2017 Aug; 74(8):933-940. PubMed ID: 28595287
[TBL] [Abstract][Full Text] [Related]
9. Survival in Parkinson's disease in relation to striatal dopamine transporter binding.
Mäkinen E; Joutsa J; Vahlberg T; Kaasinen V
Parkinsonism Relat Disord; 2017 Sep; 42():66-72. PubMed ID: 28662820
[TBL] [Abstract][Full Text] [Related]
10. Lack of association between dopamine transporter loss and non-motor symptoms in patients with Parkinson's disease: a detailed PET analysis of 12 striatal subregions.
Park SB; Kwon KY; Lee JY; Im K; Sunwoo JS; Lee KB; Roh H; Ahn MY; Park S; Kim SJ; Oh JS; Kim JS
Neurol Sci; 2019 Feb; 40(2):311-317. PubMed ID: 30415448
[TBL] [Abstract][Full Text] [Related]
11. Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients.
Santangelo G; Vitale C; Picillo M; Cuoco S; Moccia M; Pezzella D; Erro R; Longo K; Vicidomini C; Pellecchia MT; Amboni M; Brunetti A; Salvatore M; Barone P; Pappatà S
Parkinsonism Relat Disord; 2015 May; 21(5):489-93. PubMed ID: 25753457
[TBL] [Abstract][Full Text] [Related]
12. Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's disease.
Weintraub D; Newberg AB; Cary MS; Siderowf AD; Moberg PJ; Kleiner-Fisman G; Duda JE; Stern MB; Mozley D; Katz IR
J Nucl Med; 2005 Feb; 46(2):227-32. PubMed ID: 15695780
[TBL] [Abstract][Full Text] [Related]
13. Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease.
Tissingh G; Booij J; Bergmans P; Winogrodzka A; Janssen AG; van Royen EA; Stoof JC; Wolters EC
J Nucl Med; 1998 Jul; 39(7):1143-8. PubMed ID: 9669384
[TBL] [Abstract][Full Text] [Related]
14. Excessive daytime sleepiness may be associated with caudate denervation in Parkinson disease.
Yousaf T; Pagano G; Niccolini F; Politis M
J Neurol Sci; 2018 Apr; 387():220-227. PubMed ID: 29571867
[TBL] [Abstract][Full Text] [Related]
15. Selective hyposmia in Parkinson disease: association with hippocampal dopamine activity.
Bohnen NI; Gedela S; Herath P; Constantine GM; Moore RY
Neurosci Lett; 2008 Dec; 447(1):12-6. PubMed ID: 18838108
[TBL] [Abstract][Full Text] [Related]
16. Relation of overactive bladder with motor symptoms and dopamine transporter imaging in drug-naïve Parkinson's disease.
Mito Y; Yabe I; Yaguchi H; Takei T; Terae S; Tajima Y
Parkinsonism Relat Disord; 2018 May; 50():37-41. PubMed ID: 29449184
[TBL] [Abstract][Full Text] [Related]
17. Effect of striatal dopamine depletion on cognition in de novo Parkinson's disease.
Chung SJ; Yoo HS; Oh JS; Kim JS; Ye BS; Sohn YH; Lee PH
Parkinsonism Relat Disord; 2018 Jun; 51():43-48. PubMed ID: 29526657
[TBL] [Abstract][Full Text] [Related]
18. Chronic motor cortex stimulation in patients with advanced Parkinson's disease and effects on striatal dopaminergic transmission as assessed by 123I-FP-CIT SPECT: a preliminary report.
Di Giuda D; Calcagni ML; Totaro M; Cocciolillo F; Piano C; Soleti F; Fasano A; Cioni B; Bentivoglio AR; Giordano A
Nucl Med Commun; 2012 Sep; 33(9):933-40. PubMed ID: 22735298
[TBL] [Abstract][Full Text] [Related]
19. Diagnosing premotor Parkinson's disease using a two-step approach combining olfactory testing and DAT SPECT imaging.
Berendse HW; Ponsen MM
Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S26-30. PubMed ID: 20083001
[TBL] [Abstract][Full Text] [Related]
20. Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study.
Pellecchia MT; Picillo M; Santangelo G; Longo K; Moccia M; Erro R; Amboni M; Vitale C; Vicidomini C; Salvatore M; Barone P; Pappatà S
Acta Neurol Scand; 2015 May; 131(5):275-81. PubMed ID: 25644029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]